MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed net income
Net income is the profit left for shareholders after every expense, interest and tax.
MariMed's net income for the twelve months ending Sep 30, 2026 was -$15.51M. For fiscal 2025 it was -$14.48M. The highest annual figure on record is $13.47M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.48M | – |
| FY2024 | Dec 31, 2024 | -$12.47M | – |
| FY2023 | Dec 31, 2023 | -$16.03M | -219.0% |
| FY2022 | Dec 31, 2022 | $13.47M | +86.4% |
| FY2021 | Dec 31, 2021 | $7.23M | +237.0% |
| FY2020 | Dec 31, 2020 | $2.14M | – |
| FY2019 | Dec 31, 2019 | -$81.18M | – |
| FY2018 | Dec 31, 2018 | -$13.60M | – |
| FY2017 | Dec 31, 2017 | -$1.19M | – |
| FY2016 | Dec 31, 2016 | -$198.85K | – |
| FY2015 | Dec 31, 2015 | -$1.85M | – |
| FY2014 | Dec 31, 2014 | -$7.42M | – |
| FY2013 | Dec 31, 2013 | -$535.61K | – |
| FY2012 | Dec 31, 2012 | -$809.54K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.51M | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.59M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.79M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.63M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.95M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.39M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.51M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.27M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.01M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.65M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.30M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.17M | -314.0% |
| Q3 FY2023 | Sep 30, 2023 | -$4.26M | -257.4% |
| Q2 FY2023 | Jun 30, 2023 | -$958.00K | -152.6% |
| Q1 FY2023 | Mar 31, 2023 | -$645.00K | -115.4% |
| Q4 FY2022 | Dec 31, 2022 | $4.75M | – |
| Q3 FY2022 | Sep 30, 2022 | $2.71M | -35.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.82M | -55.8% |
| Q1 FY2022 | Mar 31, 2022 | $4.19M | +152.5% |
| Q4 FY2021 | Dec 31, 2021 | -$6.51M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.22M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.12M | – |
| Q3 FY2020 | Sep 30, 2020 | $1.66M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.21M | -126.0% |
| Q1 FY2020 | Mar 31, 2020 | -$2.42M | – |
| Q4 FY2019 | Dec 31, 2019 | -$78.44M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.40M | – |
| Q2 FY2019 | Jun 30, 2019 | $4.68M | – |
| Q1 FY2019 | Mar 31, 2019 | -$23.21K | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.74M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.50M | – |
| Q2 FY2018 | Jun 30, 2018 | -$461.97K | -184.5% |
| Q1 FY2018 | Mar 31, 2018 | -$1.90M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.32M | -11711.5% |
| Q3 FY2017 | Sep 30, 2017 | -$392.45K | – |
| Q2 FY2017 | Jun 30, 2017 | $547.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$33.24K | – |
| Q4 FY2016 | Dec 31, 2016 | $11.34K | – |
| Q3 FY2016 | Sep 30, 2016 | -$60.82K | – |
See a number that looks wrong?